The Medical Device Business Journal — Medical Device News & Articles | MassDevice
The eye health business arm of Johnson & Johnson (NYSE: JNJ) received the award in the “Wellness” category for its Acuvue Theravision with ketotifen (etafilcon A drug-eluting contact lens with ketotifen). The drug-eluting contact, which provides a new wearing experience for contact lens wearers who have allergic eye itch for up to 12 hours without the need for allergy drops while also providing vision correction, received FDA approval in March.
Get the full story at our sister site, Drug Delivery Business News.
Filed Under: Business/Financial News, Drug-Device Combinations, Optical/Ophthalmic Tagged With: Johnson & Johnson, Johnson & Johnson Vision
Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.